COMP <GO>
AVTR vs UNH // NET PROFIT MARGIN
Avantor Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: AVTR 1
— UNH 12
▲ NET PROFIT MARGIN LEADER: UNH
LAST: $15.61 (-2.74%) • MKT CAP: $10.58B
net-margins
-8.10%
LAST: $400.44 (-1.60%) • MKT CAP: $359.43B
net-margins
3.53%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AVTR VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AVTR | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 32.70% | 88.31% | -55.61 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.10% | 12.38% | -14.48 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.38% | 6.25% | -1.87 | UNH | /fcf-yield <GO> |
| Operating Margin | -3.80% | 5.32% | -9.12 | UNH | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -8.10% | 3.53% | -11.63 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | -3.40% | 3.33% | -6.73 | UNH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.29% | -2.29 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.88 | 3.09 | -1.21 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 43.1 | 55.1 | -12.00 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.01 | 0.33 | +0.68 | AVTR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 31.0x | 17.7x | +13.26 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.58B | $359.43B | -$348.86B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AVTR REV | UNH REV | AVTR GROSS % | UNH GROSS % | AVTR FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.55B | $447.57B | 32.7% | 88.7% | $495.0M | $16.07B |
| FY 2024 | $6.78B | $400.28B | 33.6% | 88.3% | $692.0M | $20.70B |
| FY 2023 | $6.97B | $371.62B | — | 89.6% | $556.5M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AVTR // BETA 1.01
UNH // BETA 0.33